HUE034895T2 - Eljárás vastagbéltükrözés idõzítésére pikoszulfát készítmény beadásával - Google Patents

Eljárás vastagbéltükrözés idõzítésére pikoszulfát készítmény beadásával Download PDF

Info

Publication number
HUE034895T2
HUE034895T2 HUE12745940A HUE12745940A HUE034895T2 HU E034895 T2 HUE034895 T2 HU E034895T2 HU E12745940 A HUE12745940 A HU E12745940A HU E12745940 A HUE12745940 A HU E12745940A HU E034895 T2 HUE034895 T2 HU E034895T2
Authority
HU
Hungary
Prior art keywords
colonoscopy
picoprep
halflytely
subjects
colon
Prior art date
Application number
HUE12745940A
Other languages
English (en)
Hungarian (hu)
Inventor
Raymond E Joseph
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46642617&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE034895(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of HUE034895T2 publication Critical patent/HUE034895T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
HUE12745940A 2011-07-15 2012-07-16 Eljárás vastagbéltükrözés idõzítésére pikoszulfát készítmény beadásával HUE034895T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161508189P 2011-07-15 2011-07-15

Publications (1)

Publication Number Publication Date
HUE034895T2 true HUE034895T2 (hu) 2018-03-28

Family

ID=46642617

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE12745940A HUE034895T2 (hu) 2011-07-15 2012-07-16 Eljárás vastagbéltükrözés idõzítésére pikoszulfát készítmény beadásával

Country Status (15)

Country Link
US (1) US9669110B2 (enExample)
EP (2) EP2731607B1 (enExample)
JP (2) JP6376975B2 (enExample)
KR (1) KR20140063602A (enExample)
CN (1) CN103841970A (enExample)
AU (1) AU2012284200B2 (enExample)
BR (1) BR112014000843A8 (enExample)
CA (1) CA2841751A1 (enExample)
DK (1) DK2731607T3 (enExample)
ES (1) ES2655172T3 (enExample)
HU (1) HUE034895T2 (enExample)
MX (1) MX352647B (enExample)
NO (1) NO2731607T3 (enExample)
PL (1) PL2731607T3 (enExample)
WO (1) WO2013012783A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0117057D0 (en) * 2001-07-12 2001-09-05 Ferring Bv Pharmaceutical composition
TWI539959B (zh) 2008-02-11 2016-07-01 菲瑞茵國際中心股份有限公司 治療轉移階段攝護腺癌的方法
CN105663059A (zh) * 2009-05-01 2016-06-15 辉凌公司 用于治疗前列腺癌的组合物
US20110039787A1 (en) * 2009-07-06 2011-02-17 Ferring International Center S.A. Compositions, kits and methods for treating benign prostate hyperplasia
DK2632934T3 (en) 2010-10-27 2017-01-23 Ferring Bv Process for the preparation of Degarelix and its intermediates
EP2447276A1 (en) 2010-10-27 2012-05-02 Ferring B.V. Process for the manufacture of Degarelix and its intermediates
JO3755B1 (ar) 2011-01-26 2021-01-31 Ferring Bv تركيبات تستوستيرون
SI2854831T1 (sl) 2012-06-01 2024-11-29 Ferring B.V. Izdelava degareliksa
CN103405395B (zh) * 2013-08-23 2015-04-22 山东省医药工业研究所 匹可硫酸钠肠溶片及其制备方法
KR101420315B1 (ko) 2014-03-19 2014-07-17 남봉길 약학적 액제 조성물
CN109310774A (zh) * 2015-08-17 2019-02-05 费林股份公司 含有匹可硫酸盐和柠檬酸镁的液体制剂
CN105456264B (zh) * 2015-12-03 2018-07-10 广州瑞尔医药科技有限公司 双效缓泻的药物组合物及其制备方法
TW201804996A (zh) 2016-07-08 2018-02-16 輝凌責任有限公司 含有匹可硫酸鹽(picosulfate)之安定液體調配物
GB2559405A (en) * 2017-02-06 2018-08-08 Owlstone Med Ltd Improvements in or relating to preparation of subjects for medical or veterinary examination

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110076339A1 (en) * 2008-05-23 2011-03-31 Kingston General Hospital Colon Cleansing Method and Kit
US20140087007A1 (en) 2012-09-27 2014-03-27 Braintree Laboratories, Inc. Bowel cleansing preparations

Also Published As

Publication number Publication date
MX352647B (es) 2017-12-04
JP2017061560A (ja) 2017-03-30
DK2731607T3 (en) 2018-01-02
MX2014000593A (es) 2014-07-30
BR112014000843A8 (pt) 2017-10-10
WO2013012783A1 (en) 2013-01-24
US20130018223A1 (en) 2013-01-17
AU2012284200A1 (en) 2014-02-06
JP2014520884A (ja) 2014-08-25
KR20140063602A (ko) 2014-05-27
CN103841970A (zh) 2014-06-04
EP2731607B1 (en) 2017-10-11
CA2841751A1 (en) 2013-01-24
AU2012284200B2 (en) 2016-09-22
BR112014000843A2 (pt) 2017-08-22
EP3269368A1 (en) 2018-01-17
ES2655172T3 (es) 2018-02-19
US9669110B2 (en) 2017-06-06
JP6376975B2 (ja) 2018-08-22
PL2731607T3 (pl) 2018-03-30
EP2731607A1 (en) 2014-05-21
NO2731607T3 (enExample) 2018-03-10

Similar Documents

Publication Publication Date Title
DK2731607T3 (en) Method for adjusting the timing of a colonoscopy in which a picosulfate composition is administered.
Curran et al. Oral sodium phosphate solution: a review of its use as a colorectal cleanser
Hookey et al. Lack of benefit of active preparation compared with a clear fluid–only diet in small-bowel visualization for video capsule endoscopy: results of a randomized, blinded, controlled trial
Albright et al. Hyperparathyroidism: a common and polymorphic condition as illustrated by seventeen proved cases from one clinic
US20230190662A1 (en) Efficacy of a Gastro-Retentive Bile Acid Sequestrant Dosage Form
Ioannou et al. Diagnosis of mercurial teeth in a possible case of congenital syphilis and tuberculosis in a 19th century child skeleton
Fitzpatrick et al. Histiocytosis X
Lee et al. Comparison of the efficacy and safety of sodium phosphate tablets and polyethylene glycol solution for bowel cleansing in healthy Korean adults
EP2300006A1 (en) Colon cleansing method and kit
US20140087007A1 (en) Bowel cleansing preparations
WO2005120501A1 (en) Method of bowel cleansing
HK1198006A (en) Method for timing a colonoscopy wherein a picosulate composition is administered
HK1198006B (en) Method for timing a colonoscopy wherein a picosulate composition is administered
US20130052143A1 (en) Liquid preparation for oral administration to be used in ct colonography, and composition for digestive tract imaging
US7378081B2 (en) Composition and method for direct visualization of the human appendix
Burch The problem of gallblader disease among Pima Indians
Cheng et al. 3 Liter Polyethylene Glycol is Not Inferior to The Standard Bowel Preparation in Chinese Population with Equal Efficacy: A Randomized, Controlled Trial
Xu et al. To compare patient's compliance and efficacy of intestinal cleanser alternately used with PEG-ELS and iced tea drink with the mixture of PEG-ELS and iced tea drink: a prospective randomised controlled study
Li et al. A retrospective cohort study of gastrografin in the management of adhesive small bowel obstruction during pregnancy
US20240350426A1 (en) Bowel cleansing composition with reduced dosage on the day of examination
WO2024256873A1 (en) Methods of administering safe colon cleansing compositions
Shields Peutz-jeghers syndrome: Perhaps not so benign
Ahmed Abdi Comparison between two different colon cleansing methods prior to colonoscopy
Katz et al. A dual-action, low-volume bowel cleanser
Wei et al. Quality of colon cancer pathology reporting: A process of care study